News Alert: CDC and FDA Issue Framework to Aid Clinicians for Treating Vaping

Agencies continue their investigation into the underlying cause of electronic cigarette/vaping-associated lung injury.

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to investigate the underlying cause of electronic cigarette/vaping-associated lung injury (EVALI).   

In order to assist public health response in recognizing and treating EVALI, the CDC and FDA have developed a framework to aid clinicians with an initial assessment, evaluation, management, and follow-up. The quicker the injury is recognized and treated, the better mortality and morbidity are reduced.

EVALI does not have a test that confirms the diagnosis. All potential diagnoses are eliminated to identify this condition. If EVALI is suspected, it is important to obtain the patient’s history regarding substance use, as well as electronic cigarette usage.

Clinical Evaluation

The physician should look for cough, chest pain, and shortness of breath. Some patients have presented with abdominal pain, nausea, vomiting, and diarrhea. And other patients have complained of fever, chills, and weight loss.   

Physical Examination

The physician should begin with vital signs and pulse oximetry. EVALI patients presented with oximetry < 95 percent on room air, as well as tachycardia and tachypnea. The respiratory auscultation has been unremarkable. 

Laboratory/Imaging Testing

The laboratory tests that have been positive in EVALI patients include white blood cell (WBC), C-reactive protein, erythrocyte sedimentation rate (ESR), and liver transaminases. Other laboratory testing should be guided by the patient’s presentation and history. The patient should be tested for influenza and other opportunistic infections. A provider may consider (with the patient’s consent) a urine toxicology test to determine tetrahydrocannabinol (THC) usage. A chest X-ray (CXR) should be completed, especially if the patient has a history of electronic cigarette usage. A chest CT is not required but should be considered on a case-by-case basis. The chest CT may be helpful in the diagnosis of pulmonary embolism or pneumonia.

Specialists/Consultants

A pulmonologist may be consulted to perform a bronchoalveolar lavage (BAL) or bronchoscopic lung biopsy. The specimen may be tested for respiratory infections. The benefit of lung biopsy with the staining of the specimen has not been proven to date. Depending on the severity of the patient’s respiratory distress, critical care specialists may be consulted. In some cases, EVALI patients were intubated and placed on a mechanical ventilator. Other specialists, depending on the patient’s history or presentation, include addiction specialists, psychiatrists, infectious disease specialists, etc.

Patient Management

Almost all EVALI patients have been admitted to the hospital. Patients with pulse oximetry < 95 percent on room air, respiratory distress, and other conditions that impact the patient’s respiratory function should be admitted. These patients have developed rapidly worsening respiratory conditions within 48 hours. Outpatient management of suspected EVALI patients should be considered on a case-by-case basis.

Treatment

Corticosteroids have been a treatment for EVALI patients. Corticosteroids should be held until the infection workup has been completed. Infections must be evaluated, as the influenza season started on Oct. 1. The problem regarding treatment is that the natural progression of the disease has not been identified, so investigators are unsure if the patients would improve without corticosteroids. Patients who were older than 50 were more likely to be intubated or mechanically ventilated.

At-Risk Population

The patients who are at risk include those who are older, have a history of cardiac/lung disease, or who are pregnant.  

Follow-Up Required

EVALI patients should follow up one to two weeks after discharge. The post-discharge visit should include pulse oximetry and chest X-ray. Patients who were treated with high-dose corticosteroids may require follow-up with an endocrinologist. Patients who require home oxygen may require ongoing follow-up with a pulmonologist.  

Conclusion

According to the Mortality and Morbidity Weekly Report of Oct. 22, the source of EVALI is still unknown. The risk of relapse or aftereffects of EVALI is not known at this time. The CDC is recommending that people not use an e-cigarette or vaping products containing THC. Ultimately, the CDC recommends that no e-cigarette or vaping products be used until the origin of lung injuries is known.

 

Programming Note:

Listen to Laurie Johnson report this story live today during Talk Ten Tuesday, 10-10:30 a.m. EST.

Print Friendly, PDF & Email
Facebook
Twitter
LinkedIn

Laurie M. Johnson, MS, RHIA, FAHIMA, AHIMA Approved ICD-10-CM/PCS Trainer

Laurie Johnson is currently a senior healthcare consultant for Revenue Cycle Solutions, based in Pittsburgh, Pa. Laurie is an AHIMA-approved ICD-10-CM/PCS trainer. She has more than 35 years of experience in health information management and specializes in coding and related functions. She has been a featured speaker in over 40 conferences. Laurie is a member of the ICD10monitor editorial board and is a permanent panelist on Talk Ten Tuesdays

Related Stories

Spring Brings Code Meetings and Updates

Spring Brings Code Meetings and Updates

We are approaching April 1, which means that ICD-10-CM and ICD-10-PCS will be updated with their respective guidelines. The Centers for Disease Control and Prevention

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Leveraging the CERT: A New Coding and Billing Risk Assessment Plan

Frank Cohen shows you how to leverage the Comprehensive Error Rate Testing Program (CERT) to create your own internal coding and billing risk assessment plan, including granular identification of risk areas and prioritizing audit tasks and functions resulting in decreased claim submission errors, reduced risk of audit-related damages, and a smoother, more efficient reimbursement process from Medicare.

April 9, 2024
2024 Observation Services Billing: How to Get It Right

2024 Observation Services Billing: How to Get It Right

Dr. Ronald Hirsch presents an essential “A to Z” review of Observation, including proper use for Medicare, Medicare Advantage, and commercial payers. He addresses the correct use of Observation in medical patients and surgical patients, and how to deal with the billing of unnecessary Observation services, professional fee billing, and more.

March 21, 2024
Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets

Explore the top-10 federal audit targets for 2024 in our webcast, “Top-10 Compliance Risk Areas for Hospitals & Physicians in 2024: Get Ahead of Federal Audit Targets,” featuring Certified Compliance Officer Michael G. Calahan, PA, MBA. Gain insights and best practices to proactively address risks, enhance compliance, and ensure financial well-being for your healthcare facility or practice. Join us for a comprehensive guide to successfully navigating the federal audit landscape.

February 22, 2024
Mastering Healthcare Refunds: Navigating Compliance with Confidence

Mastering Healthcare Refunds: Navigating Compliance with Confidence

Join healthcare attorney David Glaser, as he debunks refund myths, clarifies compliance essentials, and empowers healthcare professionals to safeguard facility finances. Uncover the secrets behind when to refund and why it matters. Don’t miss this crucial insight into strategic refund management.

February 29, 2024
2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

2024 ICD-10-CM/PCS Coding Clinic Update Webcast Series

HIM coding expert, Kay Piper, RHIA, CDIP, CCS, reviews the guidance and updates coders and CDIs on important information in each of the AHA’s 2024 ICD-10-CM/PCS Quarterly Coding Clinics in easy-to-access on-demand webcasts, available shortly after each official publication.

April 15, 2024

Trending News

SPRING INTO SAVINGS! Get 21% OFF during our exclusive two-day sale starting 3/21/2024. Use SPRING24 at checkout to claim this offer. Click here to learn more →